Jane Gross
Directeur/Membre du Conseil chez ATYR PHARMA, INC.
Fortune : 10 380 $ au 31/05/2024
Postes actifs de Jane Gross
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ATYR PHARMA, INC. | Directeur/Membre du Conseil | 28/06/2019 | - |
| Independent Dir/Board Member | 28/06/2019 | - | |
| BRIACELL THERAPEUTICS CORP. | Directeur/Membre du Conseil | 01/11/2021 | - |
| Independent Dir/Board Member | 01/11/2021 | - | |
| Washington Biotechnology & Biomedical Association | Directeur/Membre du Conseil | - | - |
BriaPro Therapeutics Corp.
 BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Directeur/Membre du Conseil | - | - |
| Independent Dir/Board Member | - | - |
Historique de carrière de Jane Gross
Anciens postes connus de Jane Gross
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APTEVO THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/09/2016 | 14/09/2021 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/07/2011 | 01/08/2016 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/02/2009 | 01/06/2010 |
Formation de Jane Gross
| University of California, Berkeley | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Canada | 3 |
Opérationnelle
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| APTEVO THERAPEUTICS INC. | Health Technology |
| ATYR PHARMA, INC. | Health Technology |
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Entreprise privées | 3 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
BriaPro Therapeutics Corp.
BriaPro Therapeutics Corp. Pharmaceuticals: MajorHealth Technology BriaPro Therapeutics Corp. a clinical stage biotechnology company focuses on the development of BriaTILsRx™ and PKCd inhibitors for multiple indications including cancer. The company was founded on May 15, 2023 and is headquartered West Vancouver, Canada. | Health Technology |
- Bourse
- Insiders
- Jane Gross
- Expérience
